InvestorsHub Logo
Followers 14
Posts 1165
Boards Moderated 0
Alias Born 06/14/2018

Re: Biostockclub post# 198986

Tuesday, 07/02/2019 11:11:33 PM

Tuesday, July 02, 2019 11:11:33 PM

Post# of 467765
Just amazing to me how this has Anavex written all over it.

Eisai's doubling down to find "new drugs targeting inflammation in the brain" which are "small molecule" using an approach of targeting the "right patient at the right time."

And the strategy, as you said? Precision Chemistry.

Anavex has been doing this with Hampel for years.


https://www.statnews.com/2019/04/29/eisai-dementia-incubator/
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News